GlassScriptPhysician profile
Rachel L Becker
NPI 1912531369
$8,402.75
in general payments reported to CMS, 2019-2025
26 companies · $3,018 in 2025
The $3,018 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $392 · 2022: $1,052 · 2023: $732 · 2024: $3,209 · 2025: $3,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,760 · Travel and Lodging: $3,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,759.73 |
| Travel and Lodging | $3,199.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,368.76 | 2023-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $2,095.44 | 2021-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Polynovo North America LLC | $1,002.64 | 2024-2025 | Novosorb Btm |
| Janssen Pharmaceuticals, INC | $307.29 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $274.09 | 2021-2022 | |
| Pfizer INC. | $229.71 | 2021-2023 | |
| Abiomed | $98.20 | 2025 | |
| Atricure, INC. | $96.30 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $91.12 | 2021-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $71.48 | 2022-2023 | |
| Impulse Dynamics (USA) INC. | $68.63 | 2023-2025 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $66.41 | 2021-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.04 | 2021-2022 | |
| Amgen INC. | $64.18 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $60.45 | 2022-2023 | Camzyos |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.97 | 2021-2022 | |
| Abbott Laboratories | $59.96 | 2021-2025 | Aveir |
| Actelion Pharmaceuticals US, INC. | $57.26 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $51.10 | 2021 | |
| Novo Nordisk INC | $48.64 | 2022-2023 | Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $43.69 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Esperion Therapeutics, INC. | $34.25 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $28.45 | 2021 | |
| Angiodynamics, INC. | $27.89 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.31 | 2023 | |
| Amarin Pharma, INC. | $14.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.